Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-06 9:53:9 am | Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript | SeekingAlpha |
| 2024-03-06 5:15:4 am | Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates | Zacks |
| 2024-03-06 4:17:31 am | Xeris Biopharma: Q4 Earnings Snapshot | Associated Press Finance |
| 2024-03-06 4:2:0 am | Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events | Business Wire |
| 2024-03-06 4:0:0 am | Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital | Business Wire |
| 2024-03-05 6:42:0 am | Why Xeris (XERS) Might Surprise This Earnings Season | Zacks |
| 2024-02-28 4:0:0 am | Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024 | Business Wire |
| 2024-02-05 4:0:0 am | Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference | Business Wire |
| 2024-01-11 5:30:0 am | Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza | Zacks |
Please consider a small donation if you think this website provides you with relevant information